Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fengye Kechuanping Oral Liquid (Pediatric) for Acute Bronchitis in Children
CTR20260094Phase 3Active
- Sponsor
- Yusen New Drug
- Start
- Feb 2026
- Countries
- 1
01
Overview
A Phase 3 trial of Fengye Kechuangping in acute bronchitis, sponsored by Yusen New Drug. Started Feb 2026; status: active.
02
Drugs
Fengye Kechuangping
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on CTR20260094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260094.